4
Changes in Ownership
Nuvectis Pharma, Inc. Filed Acc 0001104659-23-083472
Chairman & CEO bought 335 shares at an average $14.92 ($4,998)
From the SEC's structured data for this filing
Trades in this filing
BENTSUR RON · Chairman & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-20 | Purchase : show line 1 in the form | +110 | $15.06 | $1,657 | 3,231,669 | D |
| 2023-07-21 | Purchase : show line 2 in the form | +225 | $14.85 | $3,341 | 3,231,894 | D |
| Open-market purchases · 335 sh · avg $14.92 · $4,998 | ||||||
Loading xslF345X05/tm2321778-2_4seq1.xml…